Rollins Downgraded at UBS on Valuation Compared With Peers
Rentokil Initial Analyst Ratings
Rentokil Initial Analyst Ratings
Oppenheimer Maintains Outperform on Rentokil Initial, Raises Price Target to $47
Oppenheimer Adjusts Rentokil Initial Price Target to $35 From GBP6 on Completion of Terminix Acquisition, Maintains Outperform Rating
No Data